Recruiting OBSERVATIONAL NCT06075420

Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease (DAPTShort)

A Prospective, Multicenter, Observational Study to Evaluate the Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease

Sponsor: Genoss Co., Ltd.

Conditions Dual Antiplatelet Therapy Percutaneous Coronary Intervention

Updated 5 times since 2023 Last updated: Feb 18, 2025 Started: Aug 18, 2021 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Dual Antiplatelet Therapy and Percutaneous Coronary Intervention and is currently actively recruiting participants. Genoss Co., Ltd. leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Mar 2025 — Sep 2025 [monthly]

Recruiting
Sep 2024 — Mar 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Nov 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Genoss Co., Ltd.

Data source: Genoss Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wŏnju, South Korea